Search - tctmd.com

Displaying 461 - 480 of 520

Sort: Relevancy | Date

Presentation TCT 2014

Antegrade Transvenous Approach with Atrial Banding (Valtech) The CE Mark Study

Presenter: Ted E. Feldman, Scott Lim, Ralph Stephan von Bardeleben, Francesco Maisano

September 14, 2014

Presentation TCT 2014

Retrograde Aortic Approach with Ventricular Cinching (Guided Delivery Systems)

Presenter: Ted E. Feldman, Scott Lim, Ralph Stephan von Bardeleben, Franz X. Kleber

September 14, 2014

Presentation TCT 2014

Retrograde Aortic Approach with Pledgets (Mitalign) The CE Mark Study

Presenter: Ted E. Feldman, Scott Lim, Ralph Stephan von Bardeleben, Alexandre Abizaid

September 14, 2014

Presentation TCT 2014

The Coronary Sinus Approach: Carillon Update

Presenter: Ted E. Feldman, Scott Lim, Ralph Stephan von Bardeleben, Steven L. Goldberg

September 14, 2014

Presentation TCT 2014

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Presenter: Michael J. Lim, Hemal Gada

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

Presentation TCT 2014

Role of Exercise and Viability in the Evaluation of Mitral Regurgitation

Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim, Maurice E. Sarano

September 13, 2014

Presentation TCT 2014

Echocardiography of Mitral Regurgitation: A Critical Appraisal of Quantification and Prognostic Impact

Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim

September 13, 2014

Presentation TCT 2014

Setting the Stage: Most Important Mitral Regurgitation Studies and Events of the Last 12 Months

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Gregg W. Stone

September 13, 2014

Presentation TCT 2014

Updated US and EU Mitral Guidelines: Where Do They Agree and Disagree (and Why)?

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Robert O. Bonow

September 13, 2014

Presentation TCT 2014

TCT 788: Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High-Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Saibal Kar

September 13, 2014

Presentation TCT 2014

Just How Effective Is Biventricular Pacing for Functional Mitral Regurgitation?

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Anita Asgar

September 13, 2014

Presentation TCT 2014

Prognosis of Secondary MR in Heart Failure: New Insights from the Italian Registry

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Francesco Maisano

September 13, 2014

Presentation TCT 2014

Primary vs Secondary Mitral Regurgitation: Two Different Diseases with Different Etiologies, Prognostic Impact, and Therapies

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Jeffrey S. Borer

September 13, 2014

Presentation TCT 2014

Mitralign: Percutaneous Annuloplasty for Tricuspid Regurgitation

Presenter: Alec S. Vahanian, Scott Lim

September 13, 2014

Presentation TCT 2014

Hemodynamics of Mitral Regurgitation and Live Calculations Using the Telestrator

Presenter: Thomas H. Maloney, John R. Zimmerman, Jeff Davis

September 13, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

News Conference News TCT 2013

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

October 30, 2013

Presentation TCT 2013

TCT-93. Percutaneous Reduction of Severe Mitral Regurgitation in Elderly High Surgical Risk Patients

Presenter: Michael Rinaldi

October 29, 2013

Presentation TCT 2013

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

Presenter: Edith Lubos

October 29, 2013

Advertisement

Antegrade Transvenous Approach with Atrial Banding (Valtech) The CE Mark Study

Retrograde Aortic Approach with Ventricular Cinching (Guided Delivery Systems)

Retrograde Aortic Approach with Pledgets (Mitalign) The CE Mark Study

The Coronary Sinus Approach: Carillon Update

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

Role of Exercise and Viability in the Evaluation of Mitral Regurgitation

Echocardiography of Mitral Regurgitation: A Critical Appraisal of Quantification and Prognostic Impact

Setting the Stage: Most Important Mitral Regurgitation Studies and Events of the Last 12 Months

Updated US and EU Mitral Guidelines: Where Do They Agree and Disagree (and Why)?

TCT 788: Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High-Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Just How Effective Is Biventricular Pacing for Functional Mitral Regurgitation?

Prognosis of Secondary MR in Heart Failure: New Insights from the Italian Registry

Primary vs Secondary Mitral Regurgitation: Two Different Diseases with Different Etiologies, Prognostic Impact, and Therapies

Mitralign: Percutaneous Annuloplasty for Tricuspid Regurgitation

Hemodynamics of Mitral Regurgitation and Live Calculations Using the Telestrator

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

TCT-93. Percutaneous Reduction of Severe Mitral Regurgitation in Elderly High Surgical Risk Patients

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content